GRFS Grifols SA Total Asset Value of Company
Grifols, S.A. dominates the plasma-derived medicines segment, leveraging donor volumes and strict medical oversight. The business is currently stabilizing its cycles by reducing debt and restoring profitability. A robust network of plants in the US and Spain ensures operational resilience, as confirmed by the GURU.Markets dynamic system gross assets chart, where 23122.37 serves as the final level marker.
Analytical breakdowns and data insights for company Grifols Group (GRFS)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Grifols, S.A.|GRFS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|GRFS - Company Aggregate Debts|Debts to Book Capitalization Grifols Biemat|GRFS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Grifols|Interim Coverage Ratio grifols.com
- net income and valuation multiples indicators:
Fundamental valuation:Grifols, S.A.
Professional capital evaluates the profile of Grifols, S.A. (GRFS) through the dynamics of its asset base to eliminate the risk of investing in a depreciating asset. By analyzing the company's gross assets, calculated inversely via ROA, the investor sees a pool of resources where the high value of proprietary plasma processing plants, combined with moderate logistics outsourcing, confirms the fundamental stability and reliability of the company's operational control.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|Company Balance Sheet Assets AnaptysBio Inc. (ANAB)|Astria Therapeutics (ATXS) - Aggregate Company Assets|engene.com - Aggregate Asset Value|RAPT (RAPT Therapeutics) - Company Total Assets|Aerovate (JBIO) - Company Total Asset Base|Company Total Assets ACRS|KYTX: Total Asset Value of Company|Aggregate Company Assets Tiziana Life Sciences TLSA|cabalettabio.com (CABA) - Company Assets|VTYX - Aggregate Company Assets|THTX: Aggregate Company Assets|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|ELDN - Company Total Asset Base|Cumulative Company Assets AGEN|CLYM: Aggregate Asset Value|Aggregate Company Assets Zura Bio (ZURA)|Company Total Asset Base aTyr Pharma Inc|Adagene Inc. - Cumulative Company Assets|Company Total Asset Base ImageneBio (IMA)|Shattuck Therapeutics - Company Total Assets|EQ - Company Total Assets|CNTB (connectbiopharm.com) - Cumulative Company Assets|IMUX - Company Total Asset Base|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|IFRX - Company Balance Sheet Assets|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|ACET (adicetbio.com) - Aggregate Asset Value|Company Total Assets CELU (Celularity)|INMB (INmune Bio Inc) - Total Asset Value of Company|BRNS - Aggregate Company Assets|Company Total Asset Base Kezar Life Sciences Inc KZR|SAB Biotherapeutics (SABS) - Aggregate Company Assets|Total Asset Value of Company AKTX (akaritx.com)|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|QTTB: Aggregate Asset Value|Company Total Assets GOVX|Company Total Assets Edesa Biotech Corp (EDSA)|Aggregate Company Assets iBio, Inc. IBIO|Aggregate Asset Value CARM|XTLB - Aggregate Company Assets|Bolt Biotherapeutics (BOLT) - Cumulative Company Assets|HCWB: Company Total Assets|Aptevo Therapeutics Inc. (APVO) - Company Total Assets|Cumulative Company Assets AIM|ADTX: Aggregate Asset Value|Company Total Assets GRI|Company Total Asset Base XORTX Therapeutics Inc|Aggregate Company Assets ReShape Lifesciences HIND|REVB - Cumulative Company Assets|INDP - Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI (calcimedica.com) - Cumulative Company Assets|Affimed N.V. (AFMD) - Company Total Assets|Aggregate Company Assets Allakos Inc|Total Business Assets HOOK (HOOKIPA)|Company Total Assets IGMS|ITOS - Company Assets|Company Total Assets OCEA (Ocean Biomedical)|Company Balance Sheet Assets TC BioPharm (Holdings) Plc|THRD - Aggregate Company Assets